RIPK1-IN-37

Overview

RIPK1-IN-37 is an RIPK1 inhibitor and a ligand for the target protein for PROTAC LD5097 ( HY-179234 ). RIPK1-IN-37 can be used to synthesize PROTAC . (Pink: RIPK1 ligand ( HY-179235 ); Blue: VHL ligand ( HY-47070 ); Black: linker ( HY-179236 )).

Application

Products | Products > Disease Areas > Acute Lymphoblastic Leukemia | Products > Disease Areas > Cancer | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Leukemia/Lymphoma/Myeloma | Products > Disease Areas > Blood Disease | Products > Signaling Pathways > PROTAC | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Ligands for Target Protein for PROTAC | Products > Signaling Pathways > RIP kinase

Product Information

• Catalog No.: HY-179235
• CAS No.: 2782024-39-7
• Molecular Formula: C28H27F3N6O2
• Molecular Weight: 536.55
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source